News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • TFF Group reported a steep annual sales and profit drop, proposed a lower dividend, and warned activity will decline in fiscal 2026/27.
  • Bank of America upgraded Comet to Buy and more than doubled its price target, driving the stock up about 10% on NAND demand visibility.
  • J.P. Morgan raised Wolters Kluwer to Overweight, citing AI-driven growth acceleration, and the shares rose nearly 4%.
  • Brooks Macdonald reversed net outflows with £226m of FY26 net inflows, lifting its shares after a strong final quarter.
  • Kalshi is seeking regulatory approval to offer perpetual futures in metals, FX and energy, drawing warnings about elevated retail risk.
  • The Philippine defense chief dismissed Chinese scholars' claim on Batanes as baseless, prompting Manila concern despite no official Beijing backing.
  • WTI crude eased toward $73, with analysts warning second-half oil direction depends on OPEC+ discipline, geopolitical risks and seasonality.

Latest Articles

Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

Ernexa Therapeutics has made significant progress in manufacturing and regulatory activities for its lead oncology candidate ERNA-101, an engineered allogeneic iMSC therapy targeting immunologically cold tumors. The company plans to submit an Investigational New Drug (IND) application in Q3 2026 with a first-in-human Phase 1 study expected in Q4 20…

Duos Technologies Group Closes $55M Registered Direct Offering

Duos Technologies Group Closes $55M Registered Direct Offering

Duos Technologies Group, Inc. completed a registered direct offering, raising approximately $55 million by issuing 2 million shares and 3.8 million pre-funded warrants to a single institutional investor. The proceeds will fund the expansion and commercialization of its Edge Data Center business and support general corporate purposes. The offering w…

Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Ocular Therapeutix announced FDA alignment to submit a New Drug Application for AXPAXLI in wet age-related macular degeneration (wet AMD) in the fourth quarter of 2026, based on strong efficacy and safety data from the SOL-1 trial and interim safety results from SOL-R. The company will streamline its diabetic retinopathy program, prioritizing the H…

Tadawul slips 0.27% as insurance, media and real estate sectors weigh

Tadawul slips 0.27% as insurance, media and real estate sectors weigh

Saudi Arabia's benchmark ended lower on Wednesday with the Tadawul All Share down 0.27%. Losses in Media & Publishing, Insurance and Real Estate Development sectors contributed to the retreat. Gulf Insurance Group led winners, while Aljazira Takaful, Saudi Cement and Rabigh Refining & Petrochemical were among the biggest decliners. Market breadth f…

Pattern Group Stock Rebounds After Secondary Offering Priced at $19

Pattern Group Stock Rebounds After Secondary Offering Priced at $19

Pattern Group shares rose 2.0% in pre-market trading after pre-IPO investor Knox Lane LP priced an 8 million-share secondary offering at $19.00 per share. The deal - which will not provide proceeds to the company - was underwritten by J.P. Morgan and Goldman Sachs and includes a 30-day option to sell up to an additional 1.2 million shares. The clea…

Mountain Crest Acquisition 6 Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on June 22, 2026

Mountain Crest Acquisition 6 Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on June 22, 2026

Mountain Crest Acquisition 6 Corp., a special purpose acquisition company (SPAC), announced that starting June 22, 2026, holders of the 6,000,000 units from its IPO will have the option to trade the underlying ordinary shares and rights separately on NASDAQ under tickers MCAH and MCAHR, respectively. Units not separated will continue trading under …

Hims & Hers Shares Edge Higher Ahead of Key FDA Advisory Meeting

Hims & Hers Shares Edge Higher Ahead of Key FDA Advisory Meeting

Hims & Hers Health Inc. traded slightly higher in pre-market action, keeping near $31.54 after attention around a Leerink Partners note that outlined how a July regulatory review could enable the telehealth company to enter peptide compounding. The company is being valued largely on regulatory optionality ahead of a July 23-24 Pharmacy Compounding …

Pound Steady Above $1.34 as Dollar Strengthens Ahead of Fed Decision

Pound Steady Above $1.34 as Dollar Strengthens Ahead of Fed Decision

Sterling traded just above $1.34 and the euro held near $1.16 as the U.S. dollar firmed broadly in advance of the Federal Open Market Committee announcement under new Chair Kevin Warsh. Brent crude remained below $80 a barrel after news of a U.S.-Iran peace deal, a development that has introduced a dovish tilt to energy markets even as markets awai…

Businesses overestimate real progress on AI

Businesses overestimate real progress on AI

EXL's 2026 U.S. Enterprise AI Study highlights a large disparity between companies' perceptions of AI progress and actual performance, with only 10% qualifying as AI Leaders. These leaders have integrated AI deeply into key workflows, driving significant revenue growth (27%), cost reduction (26%), and margin improvement (22%). The study emphasizes …

Hexagon B Shares Jump After Insider Buys 55,000 Shares

Hexagon B Shares Jump After Insider Buys 55,000 Shares

Hexagon AB ser. B rose 4.8% to 84.08 SEK following a series of insider purchases totaling 55,000 shares valued at about 4.4 million SEK. The move came amid a cautiously positive session for European equities and a modest uptick in Sweden's OMXS30 index. Technical pressure on the stock since the Octave Intelligence spin-off in May 2026 has left the …

Eos Energy Enterprises Establishes Strategic Entry into Germany Through Exclusive Long-Duration Storage Partnership

Eos Energy Enterprises Establishes Strategic Entry into Germany Through Exclusive Long-Duration Storage Partnership

Eos Energy Enterprises announced a binding Master Supply Agreement with CAPAC Energy, establishing an exclusive partnership for deploying up to 2 GWh of zinc-based Indensity™ long-duration energy storage systems across Germany, Austria, and Switzerland through 2031. The agreement marks Eos' strategic entry into the critical DACH energy storage mark…

Vivakor Secures One-Year Bakken Crude Oil Transaction Expected to Generate $115 Million in Annualized Revenue

Vivakor Secures One-Year Bakken Crude Oil Transaction Expected to Generate $115 Million in Annualized Revenue

Vivakor, Inc., through its subsidiary Vivakor Supply & Trading, LLC, has secured a one-year recurring crude oil transaction involving approximately 120,000 barrels monthly from July 2026 to June 2027, expected to generate about $115 million in annualized gross revenue. This deal expands Vivakor's commercial activity and infrastructure utilization i…

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Gelteq Limited announced significant progress in its pharmaceutical and animal health programs, including the imminent start of its first human clinical trial, commencement of a veterinary clinical trial for an antiparasitic drug, and expansion of its pharmaceutical pipeline into diabetes treatment. The company also secured up to $3.5 million in st…

Foremost Clean Energy Receives Saskatchewan Exploration Incentive Funding to Advance Uranium Portfolio

Foremost Clean Energy Receives Saskatchewan Exploration Incentive Funding to Advance Uranium Portfolio

Foremost Clean Energy Ltd. announced it received a $50,000 grant from the Saskatchewan government's Targeted Mineral Exploration Incentive program to support its uranium exploration projects in the Athabasca Basin. The company plans to use the funds to advance geological and drilling activities in this key uranium-rich region. Additionally, Foremos…

Braiin Accelerates $20B+ Agentic AI Customer Experience as a Service (CXaaS) Market Expansion, Securing Landmark Australian Contract

Braiin Accelerates $20B+ Agentic AI Customer Experience as a Service (CXaaS) Market Expansion, Securing Landmark Australian Contract

Braiin Limited announces a landmark partnership with Australian enterprise BillCentral Pty Ltd to deploy its Agentic AI-powered customer experience platform, enhancing Braiin's position in the growing CXaaS market. The agreement is expected to accelerate the commercial rollout of Braiin’s AI-driven enterprise customer engagement solutions in Austra…

Ruanyun Edai Technology Unveils Smart Campus Services Business With Approximately US$9.49 Million in Cumulative Operating Revenue Since September 2025 Launch

Ruanyun Edai Technology Unveils Smart Campus Services Business With Approximately US$9.49 Million in Cumulative Operating Revenue Since September 2025 Launch

Ruanyun Edai Technology Inc. (NASDAQ: RYET) announced its Smart Campus Services business has generated approximately $9.49 million in cumulative operating revenue since its September 2025 launch, with accelerating revenue momentum in recent months. The business offers integrated campus infrastructure solutions beyond traditional education technolog…

TOMI Advances Toward NSF Certification to Address Multi-Billion-Dollar Pharmaceutical, Biotech and Cleanroom Decontamination Markets

TOMI Advances Toward NSF Certification to Address Multi-Billion-Dollar Pharmaceutical, Biotech and Cleanroom Decontamination Markets

TOMI Environmental Solutions announced progress toward achieving NSF certification for its SteraMist ionized Hydrogen Peroxide technology. This certification is expected to validate the effectiveness and compatibility of the technology for use in contamination control within pharmaceutical manufacturing, biotechnology, and cleanroom environments. A…